{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T22:47:24Z","timestamp":1778453244444,"version":"3.51.4"},"reference-count":230,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Peripartum cardiomyopathy is a disease that occurs during or after pregnancy and leads to a significant decline in cardiac function in previously healthy women. Peripartum cardiomyopathy has a varying prevalence among women depending on the part of the world where they live, but it is associated with a significant mortality and morbidity in this population. Therefore, timely diagnosis, treatment, and monitoring of this disease from its onset are of utmost importance. Although many risk factors are associated with the occurrence of peripartum cardiomyopathy, such as conditions of life, age of the woman, nutrient deficiencies, or multiple pregnancies, the exact cause of its onset remains unknown. Advances in research on the genetic associations with cardiomyopathies have provided a wealth of data indicating a possible association with peripartum cardiomyopathy, but due to numerous mutations and data inconsistencies, the exact connection remains unclear. Significant insights into the pathophysiological mechanisms underlying peripartum cardiomyopathy have been provided by the theory of an abnormal 16-kDa prolactin, which may be generated in an oxidative stress environment and lead to vascular and consequently myocardial damage. Recent studies supporting this disease mechanism also include research on the efficacy of bromocriptine (a prolactin synthesis inhibitor) in restoring cardiac function in affected patients. Despite significant progress in the research of this disease, there are still insufficient data on the safety of use of certain drugs treating heart failure during pregnancy and breastfeeding. Considering the metabolic changes that occur in different stages of pregnancy and the postpartum period, determining the correct dosing regimen of medications is of utmost importance not only for better treatment and survival of mothers but also for reducing the risk of toxic effects on the fetus.<\/jats:p>","DOI":"10.3390\/ijms251910559","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T11:32:05Z","timestamp":1727695925000},"page":"10559","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["What Do We Know about Peripartum Cardiomyopathy? Yesterday, Today, Tomorrow"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9033-5995","authenticated-orcid":false,"given":"Ratko","family":"Lasica","sequence":"first","affiliation":[{"name":"Department of Cardiology, Emergency Center, University Clinical Center of Serbia, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milika","family":"Asanin","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Department of Cardiology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jovanka","family":"Vukmirovic","sequence":"additional","affiliation":[{"name":"Faculty of Organizational Sciences, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5777-7363","authenticated-orcid":false,"given":"Lidija","family":"Maslac","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7526-1641","authenticated-orcid":false,"given":"Lidija","family":"Savic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Department of Cardiology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4059-0263","authenticated-orcid":false,"given":"Marija","family":"Zdravkovic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Clinical Center Bezanijska Kosa, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dejan","family":"Simeunovic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Department of Cardiology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Polovina","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Department of Cardiology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Milosevic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Department of Cardiology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5982-4050","authenticated-orcid":false,"given":"Dragan","family":"Matic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Department of Cardiology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Juricic","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milica","family":"Jankovic","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Marinkovic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Department of Cardiology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8841-8724","authenticated-orcid":false,"given":"Lazar","family":"Djukanovic","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"ref_1","first-page":"325","article-title":"Clinical Contributions to the Pathology, Diagnosis, and Treatment of Certain Chronic Diseases of the Heart","volume":"72","author":"Ritchie","year":"1849","journal-title":"Edinb. Med. Surg. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/bmj.1.2421.1225","article-title":"A Clinical Lecture on Heart Disease in Relation to Pregnancy and Labour: Delivered at University College Hospital","volume":"1","author":"Blacker","year":"1907","journal-title":"Br. Med. J."},{"key":"ref_3","first-page":"244","article-title":"Pregnancy and Heart Disease","volume":"13","author":"Campbell","year":"1923","journal-title":"Can. Med. Assoc. J."},{"key":"ref_4","first-page":"550","article-title":"Toxic Postpartal Heart Disease","volume":"89","author":"Hull","year":"1937","journal-title":"New Orleans Med. Surg. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/hrt.23.1.43","article-title":"Maternity and Myocardial Failure in African Women","volume":"23","author":"Seftel","year":"1961","journal-title":"Br. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/01.CIR.44.5.964","article-title":"Peripartum Cardiomyopathy","volume":"44","author":"Demakis","year":"1971","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/eurjhf\/hfq120","article-title":"Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy","volume":"12","author":"Sliwa","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4314\/mmj.v35i3.10","article-title":"Five Cases of Peripartum Cardiomyopathy in Malawi","volume":"35","author":"Matemvu","year":"2023","journal-title":"Malawi Med. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaccas.2019.12.011","article-title":"Acute Postpartum Heart Failure with Preserved Systolic Function","volume":"2","author":"Deshmukh","year":"2020","journal-title":"JACC Case Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1161\/01.CIR.0000162478.36652.7E","article-title":"Pregnancy-Associated Cardiomyopathy: Clinical Characteristics and a Comparison between Early and Late Presentation","volume":"111","author":"Elkayam","year":"2005","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/AOG.0b013e3181c4ee8c","article-title":"Cardiomyopathy and other myocardial disorders among hospitalizations for pregnancy in the United States: 2004\u20132006","volume":"115","author":"Kuklina","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCULATIONAHA.120.052395","article-title":"Genetic and phenotypic landscape of peripartum cardiomyopathy","volume":"143","author":"Goli","year":"2021","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1536\/ihj.18-729","article-title":"Worldwide incidence of peripartum cardiomyopathy and overall maternal mortality","volume":"60","author":"Isogai","year":"2019","journal-title":"Int. Heart J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jacc.2009.09.043","article-title":"African-American women have a higher risk for developing peripartum cardiomyopathy","volume":"55","author":"Gentry","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_15","first-page":"228","article-title":"Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital","volume":"17","author":"Isezuo","year":"2007","journal-title":"Ethn. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4065\/80.12.1602","article-title":"Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution","volume":"80","author":"Fett","year":"2005","journal-title":"Mayo Clin. Proc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/ejhf.882","article-title":"Peripartum cardiomyopathy in Denmark: A retrospective, population-based study of incidence, management and outcome","volume":"19","author":"Johansen","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1253\/circj.CJ-10-1214","article-title":"Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. Results from the Japanese Nationwide survey of peripartum cardiomyopathy","volume":"75","author":"Kamiya","year":"2011","journal-title":"Circ. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1093\/eurheartj\/ehad626","article-title":"A 20-year population study of peripartum cardiomyopathy","volume":"44","author":"Jackson","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/CIRCULATIONAHA.115.020491","article-title":"Peripartum cardiomyopathy","volume":"133","author":"Arany","year":"2016","journal-title":"Circulation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1001\/jamacardio.2017.3574","article-title":"Comparison of clinical characteristics and outcomes of peripartum cardiomyopathy between African American and non-African American women","volume":"2","author":"Irizarry","year":"2017","journal-title":"JAMA Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e004134","DOI":"10.1161\/CIRCHEARTFAILURE.117.004134","article-title":"Incidence, Risk Factors, and Clinical Characteristics of Peripartum Cardiomyopathy in South Korea","volume":"11","author":"Lee","year":"2018","journal-title":"Circ. Heart Fail."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e003797","DOI":"10.1161\/CIRCHEARTFAILURE.116.003797","article-title":"Impact of Preeclampsia on Clinical and Functional Outcomes in Women with Peripartum Cardiomyopathy","volume":"10","author":"Lindley","year":"2017","journal-title":"Circ. Heart Fail."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.jacc.2013.08.717","article-title":"The relationship between pre-eclampsia and peripartum cardiomyopathy: A systematic review and meta-analysis","volume":"62","author":"Bello","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.preghy.2023.11.004","article-title":"Peripartum cardiomyopathy delivery hospitalization and postpartum readmission trends, risk factors, and outcomes","volume":"34","author":"Azad","year":"2023","journal-title":"Pregnancy Hypertens."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/AOG.0b013e31826e46a1","article-title":"Peripartum cardiomyopathy: Population-based birth prevalence and 7-year mortality","volume":"120","author":"Harper","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S1701-2163(15)30545-4","article-title":"Gestational hypertension and preeclampsia: Are they the same disease?","volume":"36","author":"Melamed","year":"2014","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_28","first-page":"857","article-title":"The Relationship Between Peripartum Cardiomyopathy and Preeclampsia\u2014Pathogenesis, Diagnosis and Management","volume":"23","author":"Kubik","year":"2022","journal-title":"J. Multidiscip. Healthc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/ejhf.780","article-title":"Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM","volume":"19","author":"Sliwa","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jacc.2019.11.014","article-title":"Peripartum Cardiomyopathy: JACC State-of-the-Art Review","volume":"75","author":"Davis","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ihj.2022.04.009","article-title":"Pre-pregnancy obesity and the risk of peripartum cardiomyopathy: A systematic review and meta-analysis","volume":"74","author":"Putra","year":"2022","journal-title":"Indian Heart J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.cjca.2017.02.008","article-title":"Association Between Diabetes During Pregnancy and Peripartum Cardiomyopathy: A Population-Level Analysis of 309,825 Women","volume":"33","author":"Dhesi","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.3390\/ijms16047644","article-title":"Serum selenium and ceruloplasmin in nigerians with peripartum cardiomyopathy","volume":"16","author":"Karaye","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0167-5273(92)90108-F","article-title":"A low plasma selenium is a risk factor for peripartum cardiomyopathy. A comparative study in Sahelian Africa","volume":"36","author":"Simonoff","year":"1992","journal-title":"Int. J. Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e001430","DOI":"10.1136\/openhrt-2020-001430","article-title":"Systematic review and meta-analysis of prolactin and iron deficiency in peripartum cardiomyopathy","volume":"7","author":"Cherubin","year":"2020","journal-title":"Open Heart"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0167-5273(02)00359-5","article-title":"Peripartum cardiomyopathy: A selenium disconnection and an autoimmune connection","volume":"86","author":"Fett","year":"2002","journal-title":"Int. J. Cardiol."},{"key":"ref_37","first-page":"377","article-title":"Peripartum cardiomyopathy characteristics and outcome in a tertiary care hospital","volume":"60","author":"Hasan","year":"2010","journal-title":"J. Pak. Med. Assoc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e001056","DOI":"10.1161\/JAHA.114.001056","article-title":"Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: A nationwide population-based study","volume":"3","author":"Kolte","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jaccao.2019.09.008","article-title":"Increased Cancer Prevalence in Peripartum Cardiomyopathy","volume":"1","author":"Pfeffer","year":"2019","journal-title":"JACC CardioOncol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Chait-Rubinek, L., Mariani, J.A., Goroncy, N., Herschtal, A., Wheeler, G.C., Dwyer, M.K., Seymour, J.F., and Campbell, B.A. (2019). A Retrospective Evaluation of Risk of Peripartum Cardiac Dysfunction in Survivors of Childhood, Adolescent and Young Adult Malignancies. Cancers, 11.","DOI":"10.3390\/cancers11081046"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Wolfe, D.S., Liu, C., Alboucai, J., Karten, A., Mushi, J., Yellin, S., Berkowitz, J.L., Vega, S., Felix, N., and Liaqat, W. (2022). Maternal Outcomes in Women with Peripartum Cardiomyopathy versus Age and Race-Matched Peers in an Urban US Community. J. Cardiovasc. Dev. Dis., 9.","DOI":"10.3390\/jcdd9080250"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"131596","DOI":"10.1016\/j.ijcard.2023.131596","article-title":"Socio-economic factors determine maternal and neonatal outcomes in women with peripartum cardiomyopathy: A study of the ESC EORP PPCM registry","volume":"398","author":"Sliwa","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cardfail.2020.12.022","article-title":"Risk Prediction for Peripartum Cardiomyopathy in Delivering Mothers: A Validated Risk Model","volume":"2","author":"Davis","year":"2021","journal-title":"J. Card. Fail."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e003349","DOI":"10.1161\/CIRCHEARTFAILURE.116.003349","article-title":"Angiogenic Imbalance and Residual Myocardial Injury in Recovered Peripartum Cardiomyopathy Patients","volume":"9","author":"Goland","year":"2016","journal-title":"Circ. Heart Fail."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"101716","DOI":"10.1016\/j.cpcardiol.2023.101716","article-title":"Peripartum Cardiomyopathy: Current Understanding of Pathophysiology, Diagnostic Workup, Management, and Outcomes","volume":"48","author":"Koziol","year":"2023","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s10741-020-10061-x","article-title":"Peripartum Cardiomyopathy: A Review","volume":"26","author":"Iorgoveanu","year":"2021","journal-title":"Heart Fail. Rev."},{"key":"ref_47","first-page":"H191","article-title":"Guidelines for Assessing Maternal Cardiovascular Physiology During Pregnancy and Postpartum","volume":"327","author":"Collins","year":"2024","journal-title":"Am. J. Physiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/ajh\/hpac132","article-title":"Alterations in Vessel Hemodynamics across Uncomplicated Pregnancy","volume":"36","author":"Daskalopoulou","year":"2023","journal-title":"Am. J. Hypertesion"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/cvr\/cvu013","article-title":"Pregnancy as a Cardiac Stress Model","volume":"101","author":"Chung","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_50","first-page":"1674S","article-title":"Gestational Diabetes and Insulin Resistance: Role in Short- and Long-Term Implications for Mother and Fetus","volume":"133","author":"Catalano","year":"2003","journal-title":"Nutrients"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.placenta.2020.03.007","article-title":"Maternal Hypercholesterolemia during Pregnancy: Potential Modulation of Cholesterol Transport through the Human Placenta and Lipoprotein Profile in Maternal and Neonatal Circulation","volume":"94","author":"Cantin","year":"2020","journal-title":"Placenta"},{"key":"ref_52","unstructured":"Wild, R., and Feingold, K.R. (2024, September 26). Effect of Pregnancy on Lipid Metabolism and Lipoprotein Levels, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK498654\/."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1530\/JOE-16-0340","article-title":"Vascular Adaptation in Pregnancy and Endothelial Dysfunction in Preeclampsia","volume":"232","author":"Boeldt","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"B90","DOI":"10.1093\/eurheartj\/suz033","article-title":"Myocarditis Evolving in Cardiomyopathy: When Genetics and Offending Causes Work Together","volume":"21","author":"Cannata","year":"2019","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"13451","DOI":"10.12998\/wjcc.v10.i36.13451","article-title":"Development of Dilated Cardiomyopathy with a Long Latent Period Followed by Viral Fulminant Myocarditis: A Case Report","volume":"10","author":"Lee","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ajog.2005.01.022","article-title":"High Prevalence of Viral Genomes and Inflammation in Peripartum Cardiomyopathy","volume":"193","author":"Klingel","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e005472","DOI":"10.1161\/JAHA.117.005472","article-title":"Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy","volume":"6","author":"Schelbert","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2169\/internalmedicine.47.0316","article-title":"Magnetic Resonance Imaging in a Patient with Peripartum Cardiomyopathy","volume":"47","author":"Kawano","year":"2008","journal-title":"Intern. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ehf2.12059","article-title":"Prognostic Implication of Right Ventricular Involvement in Peripartum Cardiomyopathy: A Cardiovascular Magnetic Resonance Study","volume":"2","author":"Haghikia","year":"2015","journal-title":"ESC Heart Fail."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1007\/s00330-008-1067-x","article-title":"Characterisation of Peripartum Cardiomyopathy by Cardiac Magnetic Resonance Imaging","volume":"18","author":"Mouquet","year":"2008","journal-title":"Eur. Radiol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Ricci, F., De Innocentiis, C., Verrengia, E., Ceriello, L., Mantini, C., Pietrangelo, C., Irsuti, F., Gabriele, S., D\u2019Alleva, A., and Khanji, M.Y. (2020). The Role of Multimodality Cardiovascular Imaging in Peripartum Cardiomyopathy. Front. Cardiovasc. Med., 7.","DOI":"10.3389\/fcvm.2020.00004"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/echo.14873","article-title":"Peripartum Cardiomyopathy in a COVID-19-infected Woman: Differential Diagnosis with Acute Myocarditis\u2014A Case Report from a Hub Institution during the COVID-19 Outbreak","volume":"37","author":"Ippolito","year":"2020","journal-title":"Echocardiography"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1161\/01.CIR.0000101920.72665.58","article-title":"Inhibition of Cardiac Myocyte Apoptosis Improves Cardiac Function and Abolishes Mortality in the Peripartum Cardiomyopathy of GAQ Transgenic Mice","volume":"108","author":"Hayakawa","year":"2003","journal-title":"Circulation"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"8121","DOI":"10.1073\/pnas.94.15.8121","article-title":"Transgenic G\u03b1q Overexpression Induces Cardiac Contractile Failure in Mice","volume":"94","author":"Sakata","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"10140","DOI":"10.1073\/pnas.95.17.10140","article-title":"Enhanced G\u03b1q Signaling: A Common Pathway Mediates Cardiac Hypertrophy and Apoptotic Heart Failure","volume":"95","author":"Adams","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/hc3401.095947","article-title":"Activation of Signal Transducer and Activator of Transcription 3 Protects Cardiomyocytes from Hypoxia\/Reoxygenation-Induced Oxidative Stress Through the Upregulation of Manganese Superoxide Dismutase","volume":"104","author":"Negoro","year":"2001","journal-title":"Circulation"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"6676","DOI":"10.1074\/jbc.M108246200","article-title":"Cardiac-Specific Activation of Signal Transducer and Activator of Transcription 3 Promotes Vascular Formation in the Heart","volume":"277","author":"Osugi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cell.2006.12.036","article-title":"A Cathepsin D-Cleaved 16 KDA Form of Prolactin Mediates Postpartum Cardiomyopathy","volume":"128","author":"Kaminski","year":"2007","journal-title":"Cell"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nm0515-537a","article-title":"Erratum: Corrigendum: PAI-1 Mediates the Antiangiogenic and Profibrinolytic Effects of 16K Prolactin","volume":"21","author":"Bajou","year":"2015","journal-title":"Nat. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1172\/JCI64365","article-title":"MicroRNA-146a Is a Therapeutic Target and Biomarker for Peripartum Cardiomyopathy","volume":"123","author":"Halkein","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.tcm.2015.01.004","article-title":"Molecular Mechanisms of Peripartum Cardiomyopathy: A Vascular\/Hormonal Hypothesis","volume":"25","author":"Bello","year":"2015","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_72","first-page":"3027363","article-title":"Placental Growth Factor, Soluble FMS-like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia","volume":"2016","author":"Gabor","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess Placental Soluble Fms-like Tyrosine Kinase 1 (sFlt1) May Contribute to Endothelial Dysfunction, Hypertension, and Proteinuria in Preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jchf.2016.01.004","article-title":"Relaxin-2 and Soluble FLT1 Levels in Peripartum Cardiomyopathy","volume":"4","author":"Damp","year":"2016","journal-title":"JACC Heart Fail."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature11040","article-title":"Cardiac Angiogenic Imbalance Leads to Peripartum Cardiomyopathy","volume":"485","author":"Patten","year":"2012","journal-title":"Nature"},{"key":"ref_76","first-page":"394","article-title":"Frequency and clinical genetics of familial dilated cardiomyopathy in Cape Town: Implications for the evaluation of patients with unexplained cardiomyopathy","volume":"1010","author":"Ntusi","year":"2011","journal-title":"S. Afr. Med. J."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jacc.2004.11.066","article-title":"Clinical and Genetic Issues in Familial Dilated Cardiomyopathy","volume":"45","author":"Burkett","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ehf2.13100","article-title":"Differences between Familial and Sporadic Dilated Cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis Registry","volume":"8","author":"Asselbergs","year":"2020","journal-title":"ESC Heart Fail."},{"key":"ref_79","first-page":"886","article-title":"Familial peripartum cardiomyopathy after molar pregnancy","volume":"81","author":"Massad","year":"1993","journal-title":"Obstet. Gynecol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-8703(95)90032-2","article-title":"Familial Occurrence of Peripartum Cardiomyopathy","volume":"129","author":"Pearl","year":"1995","journal-title":"Am. Heart J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1161\/CIRCULATIONAHA.109.931220","article-title":"Rare Variant Mutations in Pregnancy-Associated or Peripartum Cardiomyopathy","volume":"121","author":"Morales","year":"2010","journal-title":"Circulation"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijcard.2008.05.035","article-title":"Can Peripartum Cardiomyopathy Be Familial?","volume":"137","author":"Baruteau","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jccase.2015.05.002","article-title":"Familial Occurrence of Peripartum Cardiomyopathy: Genetic Origin, Unrecognized Dilated Cardiomyopathy or Chance Effect?","volume":"12","author":"Canpolat","year":"2015","journal-title":"J. Cardiol. Case"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0167-5273(02)00357-1","article-title":"Mother\u2013Daughter Peripartum Cardiomyopathy","volume":"86","author":"Fett","year":"2002","journal-title":"Int. J. Cardiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1002\/ehf2.14141","article-title":"Contemporary Outcome of Subsequent Pregnancies in Patients with Previous Peripartum Cardiomyopathy","volume":"9","author":"Goland","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/AOG.0000000000002439","article-title":"Subsequent Pregnancy Outcomes in Patients with Peripartum Cardiomyopathy","volume":"131","author":"Codsi","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijgo.2009.10.011","article-title":"Risk of Heart Failure Relapse in Subsequent Pregnancy among Peripartum Cardiomyopathy Mothers","volume":"109","author":"Fett","year":"2009","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e002626","DOI":"10.1136\/openhrt-2024-002626","article-title":"Outcomes of Subsequent Pregnancy in Women with Peripartum Cardiomyopathy: A Systematic Review and Meta-Analysis","volume":"11","author":"Wijayanto","year":"2024","journal-title":"Open Heart"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"108366","DOI":"10.1007\/s00395-013-0366-9","article-title":"Phenotyping and Outcome on Contemporary Management in a German Cohort of Patients with Peripartum Cardiomyopathy","volume":"108","author":"Haghikia","year":"2013","journal-title":"Basic Res. Cardiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ppedcard.2014.10.003","article-title":"Genetic Causes of Dilated Cardiomyopathy","volume":"37","author":"Mestroni","year":"2014","journal-title":"Prog. Pediatr. Cardiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1161\/CIRCULATIONAHA.109.929646","article-title":"Peripartum Cardiomyopathy as a Part of Familial Dilated Cardiomyopathy","volume":"121","author":"Jongbloed","year":"2010","journal-title":"Circulation"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Wang, S., Zhang, Z., He, J., Liu, J., Guo, X., Chu, H., Xu, H., and Wang, Y. (2023). Comprehensive Review on Gene Mutations Contributing to Dilated Cardiomyopathy. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1296389"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/cvr\/cvaa316","article-title":"Titin-Truncating Mutations Associated with Dilated Cardiomyopathy Alter Length-Dependent Activation and Its Modulation via Phosphorylation","volume":"118","author":"Vikhorev","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1505517","article-title":"Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies","volume":"374","author":"Ware","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"820","DOI":"10.12659\/AJCR.909601","article-title":"Severe Course of Peripartum Cardiomyopathy and Subsequent Recovery in a Patient with a Novel TTN Gene-Truncating Mutation","volume":"19","author":"Kryczka","year":"2018","journal-title":"Am. J. Case Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1093\/eurheartj\/ehu050","article-title":"Titin Gene Mutations Are Common in Families with Both Peripartum Cardiomyopathy and Dilated Cardiomyopathy","volume":"35","author":"Posafalvi","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ahj.2008.01.026","article-title":"Lamin A\/C Mutation Analysis in a Cohort of 324 Unrelated Patients with Idiopathic or Familial Dilated Cardiomyopathy","volume":"156","author":"Parks","year":"2008","journal-title":"Am. Heart J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0735-1097(02)02954-6","article-title":"Natural History of Dilated Cardiomyopathy Due to Lamin A\/C Gene Mutations","volume":"41","author":"Taylor","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0735-1097(02)01724-2","article-title":"Autosomal Dominant Dilated Cardiomyopathy with Atrioventricular Block: A Lamin A\/C Defect-Related Disease","volume":"39","author":"Arbustini","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Shah, D., Virtanen, L., Prajapati, C., Kiamehr, M., Gullmets, J., West, G., Kreutzer, J., Pekkanen-Mattila, M., Heli\u00f6, T., and Kallio, P. (2019). Modeling of LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cells. Cells, 8.","DOI":"10.3390\/cells8060594"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e024960","DOI":"10.1161\/JAHA.121.024960","article-title":"Pregnancy and Progression of Cardiomyopathy in Women with LMNA Genotype-Positive","volume":"11","author":"Castrini","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_102","first-page":"2003","article-title":"A Novel LMNA Nonsense Mutation Causes Two Distinct Phenotypes of Cardiomyopathy with High Risk of Sudden Cardiac Death in a Large Five-Generation Family","volume":"20","author":"Steinfurt","year":"2018","journal-title":"EP Eur."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.jacc.2010.09.084","article-title":"SCN5A Mutations Associate with Arrhythmic Dilated Cardiomyopathy and Commonly Localize to the Voltage-Sensing Mechanism","volume":"57","author":"McNair","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejheart.2006.04.007","article-title":"Mutational Screening of Phospholamban Gene in Hypertrophic and Idiopathic Dilated Cardiomyopathy and Functional Study of the PLN\u201342 C>G Mutation","volume":"9","author":"Medin","year":"2007","journal-title":"Eur. J. Heart Fail."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Fish, M., Shaboodien, G., Kraus, S., Sliwa, K., Seidman, C.E., Burke, M.A., Crotti, L., Schwartz, P.J., and Mayosi, B.M. (2016). Mutation Analysis of the Phospholamban Gene in 315 South Africans with Dilated, Hypertrophic, Peripartum and Arrhythmogenic Right Ventricular Cardiomyopathies. Sci. Rep., 6.","DOI":"10.1038\/srep22235"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s12551-018-0443-2","article-title":"Intermediate Filaments in Cardiomyopathy","volume":"10","author":"Tsikitis","year":"2018","journal-title":"Biophys. Rev."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1053-2498(00)00240-0","article-title":"Cardiomyopathy in a Carrier of Duchenne\u2019s Muscular Dystrophy","volume":"20","author":"Davies","year":"2001","journal-title":"J. Heart Lung Transplant."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.hlc.2012.11.015","article-title":"Peripartum Cardiomyopathy in a Previously Asymptomatic Carrier of Duchenne Muscular Dystrophy","volume":"22","author":"Cheng","year":"2013","journal-title":"Heart Lung Circ."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1242\/jcs.184770","article-title":"Danon Disease\u2014Dysregulation of Autophagy in a Multisystem Disorder with Cardiomyopathy","volume":"129","author":"Rowland","year":"2016","journal-title":"J. Cell Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1161\/CIRCGENETICS.110.959205","article-title":"Genome-Wide Significance and Replication of the Chromosome 12P11.22 Locus near the PTHLH Gene for Peripartum Cardiomyopathy","volume":"4","author":"Horne","year":"2011","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Kryczka, K., Demkow, M., and Dzieli\u0144ska, Z. (2024). Biomarkers in Peripartum Cardiomyopathy\u2014What We Know and What Is Still to Be Found. Biomolecules, 14.","DOI":"10.3390\/biom14010103"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e002683","DOI":"10.1161\/CIRCHEARTFAILURE.115.002683","article-title":"GNB3 C825T Polymorphism and Myocardial Recovery in Peripartum Cardiomyopathy","volume":"9","author":"Sheppard","year":"2016","journal-title":"Circ. Heart Fail."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/ejhf.3246","article-title":"Multidisciplinary Care of Peripartum Heart Failure: A Scientific Statement of the Heart Failure Association of the ESC","volume":"26","author":"Rakisheva","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/ejhf.586","article-title":"Current Management of Patients with Severe Acute Peripartum Cardiomyopathy: Practical Guidance from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy","volume":"18","author":"Bauersachs","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra2306667","article-title":"Peripartum Cardiomyopathy","volume":"390","author":"Arany","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC Guidelines for the Management of Cardiovascular Diseases during Pregnancy","volume":"39","author":"Bauersachs","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/ejhf.1493","article-title":"Pathophysiology, Diagnosis and Management of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy","volume":"21","author":"Bauersachs","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_120","first-page":"e185","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1002\/ehf2.13646","article-title":"\u2018Time Is Prognosis\u2019 in Heart Failure: Time-to-treatment Initiation as a Modifiable Risk Factor","volume":"8","author":"Abdin","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jchf.2017.12.017","article-title":"The Effect of Door-to-Diuretic Time on Clinical Outcomes in Patients with Acute Heart Failure","volume":"6","author":"Park","year":"2018","journal-title":"JACC Heart Fail."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.xjon.2022.02.028","article-title":"Invasive and Noninvasive Cardiovascular Monitoring Options for Cardiac Surgery","volume":"10","author":"Recco","year":"2022","journal-title":"JTCVS Open"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/hrt.2009.175257","article-title":"Potentially Detrimental Cardiovascular Effects of Oxygen in Patients with Chronic Left Ventricular Systolic Dysfunction","volume":"96","author":"Park","year":"2010","journal-title":"Heart"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1042\/cs0990057","article-title":"Supplemental Oxygen Does Not Modulate Responses to Acetylcholine or Ascorbic Acid in the Forearm of Patients with Congestive Heart Failure","volume":"99","author":"Murchie","year":"2000","journal-title":"Clin. Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"H822","DOI":"10.1152\/ajpheart.1986.250.5.H822","article-title":"Superoxide Anions and Hyperoxia Inactivate Endothelium-Derived Relaxing Factor","volume":"250","author":"Rubanyi","year":"1986","journal-title":"AJP Heart Circ. Physiol."},{"key":"ref_127","first-page":"161","article-title":"Non-Invasive Ventilation in a Pregnancy with Severe Pneumonia","volume":"21","author":"Mazlan","year":"2017","journal-title":"Respir. Med. Case Rep."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ajog.2003.11.019","article-title":"Pregnancy and Perinatal Outcomes of Women with Severe Acute Respiratory Syndrome","volume":"191","author":"Wong","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1002\/ehf2.13030","article-title":"Clinical Presentation and Outcomes of Peripartum Cardiomyopathy in the Middle East: A Cohort from Seven Arab Countries","volume":"7","author":"Salam","year":"2020","journal-title":"ESC Heart Fail."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.20452\/pamw.705","article-title":"Noninvasive Positive Pressure Ventilation Effect on Mortality in Acute Cardiogenic Pulmonary Edema: A Pragmatic Meta-analysis","volume":"119","author":"Potts","year":"2009","journal-title":"Pol. Arch. Med. Wewn."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"590","DOI":"10.7326\/0003-4819-152-9-201005040-00009","article-title":"Meta-Analysis: Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema","volume":"152","author":"Weng","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/CCM.0000000000000819","article-title":"Noninvasive Ventilation and Survival in Acute Care Settings","volume":"43","author":"Cabrini","year":"2015","journal-title":"Crit. Care Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/01.CIR.91.6.1725","article-title":"Effect of Continuous Positive Airway Pressure on Intrathoracic and Left Ventricular Transmural Pressures in Patients with Congestive Heart Failure","volume":"91","author":"Naughton","year":"1995","journal-title":"Circulation"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa0707992","article-title":"Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema","volume":"359","author":"Gray","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1093\/eurheartj\/ehm502","article-title":"Randomized Study of Out-of-Hospital Continuous Positive Airway Pressure for Acute Cardiogenic Pulmonary Oedema: Physiological and Clinical Effects","volume":"28","author":"Plaisance","year":"2007","journal-title":"Eur. Heart J."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1001\/jama.294.24.3124","article-title":"Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema","volume":"294","author":"Masip","year":"2005","journal-title":"JAMA"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1183\/09059180.00008113","article-title":"Successful Use of Noninvasive Ventilation in Pregnancy","volume":"23","author":"Allred","year":"2014","journal-title":"Eur. Respir. Rev."},{"key":"ref_138","first-page":"874","article-title":"Management of Respiratory Deterioration in a Pregnant Patient with Severe Kyphoscoliosis by Non-Invasive Positive Pressure Ventilation","volume":"114","author":"Habeler","year":"2002","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_139","first-page":"115","article-title":"Use of Non-Invasive Ventilation in a Pregnant Woman with Acute Respiratory Distress Syndrome Due to Pneumonia","volume":"51","author":"Banga","year":"2009","journal-title":"Indian J. Chest Dis. Allied Sci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.5005\/jp-journals-10071-24036","article-title":"Acute Respiratory Distress Syndrome in Pregnancy","volume":"25","author":"Pandya","year":"2022","journal-title":"Indian J. Crit. Care Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3904\/kjim.2016.360","article-title":"Practical Management of Peripartum Cardiomyopathy","volume":"32","author":"Kim","year":"2017","journal-title":"Korean J. Intern. Med."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","article-title":"Pharmacokinetics of Drugs in Pregnancy","volume":"39","author":"Feghali","year":"2015","journal-title":"Semin. Perinatol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10928-020-09698-w","article-title":"Drug Dosing during Pregnancy\u2014Opportunities for Physiologically Based Pharmacokinetic Models","volume":"47","author":"Abduljalil","year":"2020","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"ref_144","first-page":"44","article-title":"Use of diuretics during pregnancy","volume":"55","author":"Bozzo","year":"2009","journal-title":"Can. Fam. Physician"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Klinkmann, G., Klammt, S., J\u00e4schke, M., Henschel, J., Gloger, M., Reuter, D.A., and Mitzner, S. (2022). Impact of Albumin Binding Function on Pharmacokinetics and Pharmacodynamics of Furosemide. Medicina, 58.","DOI":"10.3390\/medicina58121780"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/jcph.1681","article-title":"A Pilot Study of the Maternal-Fetal Pharmacokinetics of Furosemide in Plasma, Urine, and Amniotic Fluid of Hypertensive Parturient Women under Cesarean Section","volume":"60","author":"Duarte","year":"2020","journal-title":"J. Clin. Pharmacol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/bcp.12086","article-title":"Renal Drug Metabolism in Humans: The Potential for Drug\u2013Endobiotic Interactions Involving Cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT)","volume":"76","author":"Knights","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0378-3782(93)90178-W","article-title":"Albumin Levels in Pregnancy: A Hypothesis\u2014Decreased Levels of Albumin Are Related to Increased Levels of Alpha-Fetoprotein","volume":"34","author":"Maher","year":"1993","journal-title":"Early Hum. Dev."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/cpt1978245560","article-title":"Placental Transfer of Furosemide","volume":"24","author":"Beermann","year":"1978","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/0976-500X.130075","article-title":"Amniotic Fluid Volume Changes in Response to Frusemide Induced Maternal Fluid Shifts","volume":"5","author":"Manikandan","year":"2014","journal-title":"J. Pharmacol. Pharmacother."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3109\/14767058.2013.852180","article-title":"Management of chronic hypertension during pregnancy with furosemide, amlodipine or aspirin: A pilot clinical trial","volume":"27","author":"Dominguez","year":"2014","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijcard.2014.09.013","article-title":"Cardiac medication during pregnancy, data from the ROPAC","volume":"177","author":"Ruys","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/0310057X0102900211","article-title":"Glyceryl trinitrate and acute uterine relaxation: A literature review","volume":"29","author":"Caponas","year":"2001","journal-title":"Anaesth. Intensive Care"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/bdra.20801","article-title":"Developmental toxicity of glyceryl trinitrate in quail embryos","volume":"91","author":"Bardai","year":"2011","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"e14482","DOI":"10.1111\/and.14482","article-title":"Endocrine disruption: Reproductive toxicity of glyceryl trinitrate and isosorbide mononitrate in male Wistar rats","volume":"54","author":"Sharif","year":"2022","journal-title":"Andrologia"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1365-2044.2012.07055.x","article-title":"Acute pulmonary oedema in pregnant women","volume":"67","author":"Dennis","year":"2012","journal-title":"Anaesthesia"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1213\/00000539-199705000-00031","article-title":"Prevention of fetal and maternal cyanide toxicity from nitroprusside with coinfusion of sodium thiosulfate in gravid ewes","volume":"84","author":"Curry","year":"1997","journal-title":"Anesth. Analg."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4037\/ajcc1992.1.2.19","article-title":"Sodium nitroprusside-induced cyanide intoxication and prevention with sodium thiosulfate prophylaxis","volume":"1","author":"Hall","year":"1992","journal-title":"Am. J. Crit. Care"},{"key":"ref_159","first-page":"349","article-title":"Low STAT3 expression sensitizes to toxic effects of \u03b2-adrenergic receptor stimulation in peripartum cardiomyopathy","volume":"38","author":"Stapel","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/cvr\/cvu034","article-title":"STAT3, a key regulator of cell-to-cell communication in the heart","volume":"102","author":"Haghikia","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.accpm.2016.02.009","article-title":"Decongestive effects of levosimendan in cardiogenic shock induced by postpartum cardiomyopathy","volume":"36","author":"Labbene","year":"2017","journal-title":"Anaesth. Crit. Care Pain Med."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Pan, J., Yang, Y.M., Zhu, J.Y., and Lu, Y.Q. (2019). Multiorgan Drug Action of Levosimendan in Critical Illnesses. Biomed Res. Int., 2019.","DOI":"10.1155\/2019\/9731467"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1002\/ehf2.13669","article-title":"Levosimendan-induced venodilation is mediated by opening of potassium channels","volume":"8","author":"Burkhoff","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/clc.23249","article-title":"Use of Impella heart pump for management of women with peripartum cardiogenic shock","volume":"42","author":"Elkayam","year":"2019","journal-title":"Clin. Cardiol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"e230822207933","DOI":"10.2174\/1573403X18666220823151854","article-title":"Review of Randomized Controlled Trials in Patients with Peripartum Cardiomyopathy","volume":"19","author":"Mujkanovic","year":"2023","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/CIRCHEARTFAILURE.113.000721","article-title":"Outcomes of patients with peripartum cardiomyopathy who received mechanical circulatory support. Data from the Interagency Registry for Mechanically Assisted Circulatory Support","volume":"7","author":"Pamboukian","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.healun.2011.11.018","article-title":"Peripartum cardiomyopathy: Post-transplant outcomes from the United Network for Organ Sharing Database","volume":"31","author":"Rasmusson","year":"2012","journal-title":"J. Heart Lung Transpl."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/asheducation-2009.1.277","article-title":"Pregnancy-associated thrombosis","volume":"2009","author":"James","year":"2009","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.thromres.2004.08.004","article-title":"Haemostatic changes in pregnancy","volume":"114","author":"Brenner","year":"2004","journal-title":"Thromb. Res."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2003-38897","article-title":"Hemostasis during normal pregnancy and puerperium","volume":"29","author":"Hellgren","year":"2003","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2147\/VHRM.S404537","article-title":"Venous Thromboembolism in Pregnancy: Challenges and Solutions","volume":"19","author":"Varrias","year":"2023","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"160","DOI":"10.25122\/jml-2022-0267","article-title":"Investigating protein C and S levels in pregnant women with recurrent early pregnancy loss versus normal pregnancy","volume":"16","author":"Mukhtar","year":"2023","journal-title":"J. Med. Life"},{"key":"ref_173","first-page":"145","article-title":"Peripartum cardiomyopathy and ventricular thrombus: A case report and review of literature","volume":"5","author":"Aksu","year":"2018","journal-title":"North. Clin. Istanb."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ehf2.14158","article-title":"Risk factors for intracardiac thrombus in peripartum cardiomyopathy: A retrospective study in China","volume":"10","author":"Fu","year":"2023","journal-title":"ESC Heart Fail."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"591","DOI":"10.5543\/tkda.2011.01534","article-title":"Do\u011fum d\u00f6nemi kardiyomiyopatisi olan gen\u00e7 bir hastada her iki ventrik\u00fclde geni\u015f apikal tromb\u00fcs ve serebral emboli geli\u015fimi [Development of biventricular large apical thrombi and cerebral embolism in a young woman with peripartum cardiomyopathy]","volume":"39","author":"Sahin","year":"2011","journal-title":"Turk. Kardiyol. Dern. Ars."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jgyn.2010.01.008","article-title":"\u00c9volution et complications thromboemboliques de la myocardiopathie idiopathique du p\u00e9ripartum au CHU de Dakar: \u00c9tude prospective \u00e0 propos de 33 cas [Evolution and thromboembolic complications of the idiopathic peripartal cardiomyopathy at Dakar University Hospital: Forward-looking study about 33 cases]","volume":"39","author":"Kane","year":"2010","journal-title":"J. Gynecol. Obstet. Biol. Reprod."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.thromres.2022.02.002","article-title":"Management of venous thromboembolism in pregnancy","volume":"211","author":"Kalaitzopoulos","year":"2022","journal-title":"Thromb. Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1001\/archinte.1989.00390100059015","article-title":"Heparin therapy during pregnancy. Risks to the fetus and mother","volume":"14","author":"Ginsberg","year":"1989","journal-title":"Arch. Intern. Med."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/s-0030-1267849","article-title":"Anticoagulation management","volume":"27","author":"Cook","year":"2010","journal-title":"Semin. Interv. Radiol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"10760296211005544","DOI":"10.1177\/10760296211005544","article-title":"Protamine Sulfate Neutralization Profile of Various Dosages of Bovine, Ovine and Porcine UFHs and Their Depolymerized Derivatives in Non-Human Primates","volume":"27","author":"Kouta","year":"2021","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Lasica, R., Asanin, M., Djukanovic, L., Radovanovic, N., Savic, L., Polovina, M., Stankovic, S., Ristic, A., Zdravkovic, M., and Lasica, A. (2022). Dilemmas in the Choice of Adequate Therapeutic Treatment in Patients with Acute Pulmonary Embolism-From Modern Recommendations to Clinical Application. Pharmaceuticals, 15.","DOI":"10.20944\/preprints202208.0027.v1"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1517\/14740338.4.3.583","article-title":"Minimising the risk of heparin-induced osteoporosis during pregnancy","volume":"4","author":"Hawkins","year":"2005","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.2147\/IJGM.S420327","article-title":"Heparin Induced Thrombocytopenia\u2014Pathophysiology, Diagnosis and Treatment: A Narrative Review","volume":"16","author":"Alhanshani","year":"2023","journal-title":"Int. J. Gen. Med."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: A systematic review of safety and efficacy","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12959-019-0213-9","article-title":"Low molecular weight heparins use in pregnancy: A practice survey from Greece and a review of the literature","volume":"17","author":"Papadakis","year":"2019","journal-title":"Thromb. J."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/bmj.326.7379.37","article-title":"Antithrombotic therapy in special circumstances. I\u2014Pregnancy and cancer","volume":"326","author":"Jilma","year":"2003","journal-title":"BMJ"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"bcr2012007344","DOI":"10.1136\/bcr-2012-007344","article-title":"Fetal warfarin syndrome","volume":"2012","author":"Starling","year":"2012","journal-title":"BMJ Case Rep."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"bcr2017223159","DOI":"10.1136\/bcr-2017-223159","article-title":"Low-dose warfarin maternal anticoagulation and fetal warfarin syndrome","volume":"2018","author":"Sousa","year":"2018","journal-title":"BMJ Case Rep."},{"key":"ref_189","first-page":"e35","article-title":"2020 ACC\/AHA Guideline for the Management of Patients with Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur. Heart J"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.thromres.2024.02.016","article-title":"Pregnancy outcomes in Chinese women with mechanical heart valves receiving warfarin treatment throughout pregnancy: 14-year experience","volume":"236","author":"Li","year":"2024","journal-title":"Thromb. Res."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: Venous thromboembolism in the context of pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Adv."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"e884","DOI":"10.1016\/S2352-3026(20)30327-6","article-title":"Safety of direct oral anticoagulant exposure during pregnancy: A retrospective cohort study","volume":"7","author":"Tittl","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1160\/TH16-04-0305","article-title":"Pregnancy outcome in patients exposed to direct oral anticoagulants\u2014And the challenge of event reporting","volume":"116","author":"Michalski","year":"2016","journal-title":"Thromb. Haemost."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1093\/rheumatology\/keac552","article-title":"British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: Comorbidity medications used in rheumatology practice","volume":"62","author":"Schreiber","year":"2023","journal-title":"Rheumatology"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1753495X15621814","article-title":"Unplanned pregnancy on a direct oral anticoagulant (Rivaroxaban): A warning","volume":"9","author":"Myers","year":"2016","journal-title":"Obstet. Med."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00392-012-0494-5","article-title":"Pro-thrombotic condition in a woman with peripartum cardiomyopathy treated with bromocriptine and an Impella LP 2.5 heart pump","volume":"102","author":"Schroeter","year":"2013","journal-title":"Clin. Res. Cardiol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0167-5273(96)02789-1","article-title":"Myocardial infarction postpartum in patients taking bromocriptine for the prevention of breast engorgement","volume":"57","author":"Hopp","year":"1996","journal-title":"Int. J. Cardiol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1752-1947-4-80","article-title":"Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: Two case reports","volume":"4","author":"Meyer","year":"2010","journal-title":"J. Med. Case Rep."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1055\/s-0038-1675832","article-title":"Bromocriptine Use in Peripartum Cardiomyopathy: Review of Cases","volume":"8","author":"Simon","year":"2018","journal-title":"AJP Rep."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jccase.2023.11.014","article-title":"Peripartum cardiomyopathy in patients with psychiatric disorders successfully treated with bromocriptine: Two case reports","volume":"29","author":"Takanaka","year":"2023","journal-title":"J. Cardiol. Cases"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00392-018-1355-7","article-title":"Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction","volume":"108","author":"Haghikia","year":"2019","journal-title":"Clin. Res. Cardiol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ehf2.12376","article-title":"The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: Insights from the BRO-HF retrospective cohort study","volume":"6","author":"Avram","year":"2019","journal-title":"ESC Heart Fail."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10741-021-10185-8","article-title":"Effects of bromocriptine in peripartum cardiomyopathy: A systematic review and meta-analysis","volume":"27","author":"Trongtorsak","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"101461","DOI":"10.1016\/j.cpcardiol.2022.101461","article-title":"Prolactin Inhibition in Peripartum Cardiomyopathy: Systematic Review and Meta-analysis","volume":"48","author":"Kumar","year":"2023","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jacc.2018.10.075","article-title":"Use of Medication for Cardiovascular Disease During Pregnancy: JACC State-of-the-Art Review","volume":"73","author":"Halpern","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"de Bruin, R., van Dalen, S.L., Franx, S.J., Ramaswamy, V.V., Simons, S.H.P., Flint, R.B., and van den Bosch, G.E. (2022). The Risk for Neonatal Hypoglycemia and Bradycardia after Beta-Blocker Use during Pregnancy or Lactation: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health, 9.","DOI":"10.3390\/ijerph19159616"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1253\/circj.CJ-15-0617","article-title":"Beta-Blockers and Fetal Growth Restriction in Pregnant Women with Cardiovascular Disease","volume":"80","author":"Tanaka","year":"2016","journal-title":"Circ. J."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jamainternmed.2017.0608","article-title":"\u03b2-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies","volume":"177","author":"Duan","year":"2017","journal-title":"JAMA Intern. Med."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s00228-022-03382-3","article-title":"Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: A systematic review","volume":"78","author":"Mian","year":"2022","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_212","first-page":"e44043","article-title":"Beta-Blockers and Their Current Role in Maternal and Neonatal Health: A Narrative Review of the Literature","volume":"15","author":"Martinez","year":"2023","journal-title":"Cureus"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000299817","article-title":"Placental transfer of hydrochlorothiazide","volume":"11","author":"Beermann","year":"1980","journal-title":"Gynecol. Obstet. Investig."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.earlhumdev.2005.11.001","article-title":"Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists","volume":"82","author":"Quan","year":"2006","journal-title":"Early Hum. Dev."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/bdra.20102","article-title":"Angiotensin II receptor antagonist treatment during pregnancy","volume":"73","author":"Alwan","year":"2005","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/eurheartj\/ehv009","article-title":"Peripartum cardiomyopathy: Current management and future perspectives","volume":"36","author":"Haghikia","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1055\/s-2007-994324","article-title":"Reversible oligohydramnios in a pregnancy with angiotensin-converting enzyme inhibitor exposure","volume":"14","author":"Chisholm","year":"1997","journal-title":"Am. J. Perinatol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/bdra.10081","article-title":"Angiotensin II-receptor-antagonists: Further evidence of fetotoxicity but not teratogenicity","volume":"67","author":"Schaefer","year":"2003","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1681\/ASN.V391575","article-title":"Angiotensin-converting enzyme inhibitor fetopathy","volume":"3","author":"Pryde","year":"1993","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa055202","article-title":"Major congenital malformations after first-trimester exposure to ACE inhibitors","volume":"354","author":"Cooper","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00228-020-03066-w","article-title":"Ivabradine use in pregnant women-treatment indications and pregnancy outcome: An evaluation of the German Embryotox database","volume":"77","author":"Hoeltzenbein","year":"2021","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Muller, D.R.P., Stenvers, D.J., Malekzadeh, A., Holleman, F., Painter, R.C., and Siegelaar, S.E. (2023). Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: A systematic review of the evidence. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1215356"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00592-018-1134-y","article-title":"Empagliflozin, metformin and insulin degludec, during pregnancy: A case report","volume":"55","author":"Formoso","year":"2018","journal-title":"Acta Diabetol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2147\/DDDT.S239704","article-title":"Perindopril in Breast Milk and Determination of Breastfed Infant Exposure: A Prospective Observational Study","volume":"14","author":"Leggett","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_225","first-page":"278","article-title":"Enalapril treatment of a nursing with slightly impaired renal function","volume":"31","author":"Huttunen","year":"1989","journal-title":"Clin. Nephrol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00314815","article-title":"The excretion of enalapril and enalaprilat in human breast milk","volume":"38","author":"Redman","year":"1990","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_227","unstructured":"(2024, September 26). Drugs and Lactation Database (LactMed\u00ae) [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501247\/."},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Falconi, S., Okimi, A., Wesley, S., Sethi, P., Datta, P., and Krutsch, K. (2024). The concentration of maternal sacubitril\/valsartan transferred into human milk is negligible. Front. Public Health, 12.","DOI":"10.3389\/fpubh.2024.1389513"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"100901","DOI":"10.1016\/j.jacadv.2024.100901","article-title":"Recommendations for the Management of High-Risk Cardiac Delivery: ACC Cardiovascular Disease in Women Committee Panel","volume":"3","author":"Lau","year":"2024","journal-title":"JACC Adv."},{"key":"ref_230","doi-asserted-by":"crossref","unstructured":"Yam\u00e9ogo, N.V., Samadoulougou, A.K., Kagamb\u00e8ga, L.J., Kologo, K.J., Millogo, G.R.C., Thiam, A., Guenancia, C., and Zansonr\u00e9, P. (2018). Maternal and fetal prognosis of subsequent pregnancy in black 28 African women with peripartum cardiomyopathy. BMC Cardiovasc. Disord., 18.","DOI":"10.1186\/s12872-018-0856-7"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/19\/10559\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:07:56Z","timestamp":1760112476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/19\/10559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":230,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["ijms251910559"],"URL":"https:\/\/doi.org\/10.3390\/ijms251910559","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]}}}